Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology

por Roosendaal, Jeroen, Rosing, Hilde, Beijnen, Jos H.
Publicado 2020

Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibito...

por Roosendaal, Jeroen, Rosing, Hilde, Beijnen, Jos H.
Publicado 2020

Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action

por Derissen, Ellen J. B., Beijnen, Jos H.
Publicado 2020

Palladium‐induced granulomas analysed with inductively coupled plasma mass spectrometry

por Marsidi, Nick, Beijnen, Jos H., van Zuuren, Esther J.
Publicado 2018

Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review

por van Bussel, Mark T. J., Beijnen, Jos H., Brandsma, Dieta
Publicado 2019

The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins

por Loos, Nancy H.C., Beijnen, Jos H., Schinkel, Alfred H.
Publicado 2023

The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?

por Loos, Nancy H. C., Beijnen, Jos H., Schinkel, Alfred H.
Publicado 2022

Protein versus DNA as a marker for peripheral blood mononuclear cell counting

por Jansen, Robert S., Rosing, Hilde, Schellens, Jan H. M., Beijnen, Jos H.
Publicado 2009

P-gp and taxanes

por Hendrikx, Jeroen J.M.A., Beijnen, Jos H., Schinkel, Alfred H.
Publicado 2014

Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment

por van Andel, Lotte, Rosing, Hilde, Schellens, Jan HM, Beijnen, Jos H
Publicado 2018

Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation

por Palić, Semra, Bhairosing, Patrick, Beijnen, Jos H., Dorlo, Thomas P. C.
Publicado 2019

Long-term platinum retention after treatment with cisplatin and oxaliplatin

por Brouwers, Elke EM, Huitema, Alwin DR, Beijnen, Jos H, Schellens, Jan HM
Publicado 2008

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]

por Hendrikx, Jeroen J M A, Beijnen, Jos H, Huitema, Alwin D R
Publicado 2020

Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling

por Gast, Marie-Christine W, Engwegen, Judith YMN, Schellens, Jan HM, Beijnen, Jos H
Publicado 2008

Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology

por Bruin, Maaike A. C., Sonke, Gabe S., Beijnen, Jos H., Huitema, Alwin D. R.
Publicado 2022

Naked Plasmid DNA Formulation: Effect of Different Disaccharides on Stability after Lyophilisation

por Quaak, Susanne G. L., Haanen, John B. A. G., Beijnen, Jos H., Nuijen, Bastiaan
Publicado 2010

Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers

por van den Broek, Irene, Sparidans, Rolf W., Schellens, Jan H. M., Beijnen, Jos H.
Publicado 2010

Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs

por Kip, Anke E., Schellens, Jan H. M., Beijnen, Jos H., Dorlo, Thomas P. C.
Publicado 2017

ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, While OATP1A/1B, ABCG2, and CYP3A Limit Its Oral Availabili...

por Li, Wenlong, Sparidans, Rolf W., Lebre, Maria C., Beijnen, Jos H., Schinkel, Alfred H.
Publicado 2021

Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography–t...

por Susam, M. Merve, Wang, Jing, Schinkel, Alfred H., Beijnen, Jos H., Sparidans, Rolf W.
Publicado 2022